On November 11, 2024, Marvin White, Director at Emergent BioSolutions Inc (EBS, Financial), executed a sale of 14,287 shares of the company. The transaction was filed on the same day with the SEC. Following this transaction, the insider now owns 54,092 shares of Emergent BioSolutions Inc.
Emergent BioSolutions Inc is a global life sciences company focused on providing a range of specialty products for civilian and military populations that address intentional and naturally emerging public health threats. The company's products target infectious diseases, among other things.
Over the past year, Marvin White has sold a total of 14,287 shares and has not made any purchases of the company's stock. The insider transaction history for Emergent BioSolutions Inc shows a trend of more sales than purchases among insiders, with 0 insider buys and 4 insider sells over the past year.
Shares of Emergent BioSolutions Inc were trading at $11.97 on the day of the transaction. The company has a market cap of approximately $540.217 million. According to the GF Value, the stock is currently Fairly Valued with a price-to-GF-Value ratio of 1.16.
The GF Value is calculated based on historical multiples such as price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow, adjusted by a GuruFocus factor based on past returns and growth, and future business performance estimates from Morningstar analysts.
This sale by the insider could be of interest to current and potential investors, providing insight into how insiders are interacting with their holdings in the company.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
